SARS COV-2 (COVİD-19) YÖNETİMİNDE ÇİNKO, BAKIR, SELENYUM VE MAGNEZYUMUN ETKİNLİĞİ VE ÖNEMİ
Abstract
Keywords
Supporting Institution
References
- World Health Organization (WHO). Q & A on coronaviruses (COVID-19). https://www.who.int/news-room/q-a-detail/q-a-coronaviruses.(Erişim Tarihi: 25 Haziran 2021).
- World Health Organization (WHO). WHO Coronavirus Disease (COVID-19)Dashboard. https://covid19.who.int/. (Erişim tarihi: 25 Haziran 2021).
- Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized Pa- tients with COVID-19: a systematic review and meta- analysis. Arch Archives of Academic Emergency Medicine. 2020;8(1):e35. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/. Erişim Tarihi 12 Ekim 2020.
- Thomas R, Wang W, Su D. Contributions of age-related thymic involution to immunosenescence and inflammaging. Immunity and Ageing. 2020;17(2):1–17. doi: 10.1186/s12979-020-0173-8. BMC (Epub 2020 Jan 20).
- Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of 50466 hospitalized patients with 2019‐nCoV infection. Journal of Medical Virology. 2020. doi: 10.1101/2020.02.18.20024539.
- Li J, Chen Z, Nie Y, Ma Y, Guo Q, Dai, X. Prognostic symptoms on COVID-19severity. Journal of Medicine Internet Research. 2020;22(6):e19636 doi: 10.2196/19636. Pubmed PMID: 32544071.
- Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, Mayhew S. The COVID-19vaccine development landscape. Nature Reviews Drug Discovery. 2020;19;305-306. doi: 10.1038/d41573-020-00073-5.
- Centers for Disease Control and Prevention(CDC). Coronavirus (Covid-19). https://www.cdc.gov/coronavirus/2019-ncov/. (Erişim Tarihi: 12 Ekim 2020).
Details
Primary Language
Turkish
Subjects
Health Care Administration
Journal Section
Review
Authors
Mücahit Muslu
*
0000-0002-8761-5061
Türkiye
Publication Date
December 28, 2021
Submission Date
November 9, 2020
Acceptance Date
July 5, 2021
Published in Issue
Year 2021 Volume: 4 Number: 3
